anti-BCL9L antibody
CAT.NO. : ARG43189
US$ Please choose
US$ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整,请以品牌方官网实时更新的价格为准,以确保准确性。
概述
| 产品描述 | Rabbit Polyclonal antibody recognizes BCL9L |
|---|---|
| 反应物种 | Hu |
| 应用 | ICC, WB |
| 宿主 | Rabbit |
| 克隆 | Polyclonal |
| 同位型 | IgG |
| 靶点名称 | BCL9L |
| 抗原物种 | Human |
| 抗原 | A 20-amino acid peptide within aa. 20-70 of Human BCL9L. |
| 偶联标记 | Un-conjugated |
| 別名 | Protein BCL9-2; BCL9-2; B-cell CLL/lymphoma 9-like protein; DLNB11; BCL9-like protein; B-cell lymphoma 9-like protein |
应用说明
| 应用建议 |
| ||||||
|---|---|---|---|---|---|---|---|
| 应用说明 | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. | ||||||
| 阳性对照 | HeLa |
属性
| 形式 | Liquid |
|---|---|
| 纯化 | Affinity purification with immunogen. |
| 缓冲液 | PBS and 0.02% Sodium azide. |
| 抗菌剂 | 0.02% Sodium azide |
| 浓度 | 1 mg/ml |
| 存放说明 | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
| 注意事项 | For laboratory research only, not for drug, diagnostic or other use. |
生物信息
| 数据库连接 | Swiss-port # Q86UU0 Human B-cell CLL/lymphoma 9-like protein |
|---|---|
| 基因名称 | BCL9L |
| 全名 | B-cell CLL/lymphoma 9-like |
| 生物功能 | Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity). [UniProt] |
| 细胞定位 | Nucleus. [UniProt] |
| 预测分子量 | 157 kDa |
检测图片 (2)
ARG43189 anti-BCL9L antibody ICC image
Immunocytochemistry: HeLa cells stained with ARG43189 anti-BCL9L antibody at 10 µg/ml dilution.
ARG43189 anti-BCL9L antibody WB image
Western blot: HeLa cell lysate stained with ARG43189 anti-BCL9L antibody at 1 µg/ml dilution, in the absence (left) and the presence of blocking peptide (right).
New Products

